Benaroya Research Institute at Virginia Mason (BRI) works to unlock the mysteries of the immune system. Its team of world-renowned scientists is focused on identifying causes and cures for devastating diseases including diabetes, arthritis, heart disease and cancer. BRI is an international leader in immune system and autoimmune disease research with a focus on translating laboratory discoveries to real life applications.
This program focuses on identifying the causes and cures of Type 1 (autoimmune) diabetes through basic and clinical research.
This program's mission is to understand the relationship between the immune system and diseases and to design new therapies.
This program acts as an interface between the laboratory researchers, clinicians and patients to translate scientific knowledge into clinical trials.
This program focuses on diseases of the body’s tissues, heart and blood vessels—and conducts basic and translational research.
This program conducts clinical trials of new therapeutics, and studies clinical outcomes.
Learn about our researchers.
Spotlight
News & Events
- New Grants Support Heart Repair, Hepatits B and Allergy/Asthma Research Read more
- Dr. Gerald Nepom Receives UW Medicine Distinguished Alumni Award Read more
- Predicting and Preventing Autoimmune Disease on UWTV Read more
- Life Sciences Discovery Fund Awards BRI $5.57 Million for Autoimmune Disease Research Read more